EconomyEuropean drugmakers say they are ‘losing ground’ to US and Chinese rivals
Leaders of nine major European pharmaceutical companies, including AstraZeneca, GSK and Novo Nordisk, have urged European governments to act as the continent falls behind the US and China in developing new medicines and attracting investment. They called for medicines to be treated as strategic infrastructure to restore competitiveness and protect health sovereignty.
TThe Guardian★★★★☆2026-09-22 15:04Original
European drugmakers say they are ‘losing ground’ to US and Chinese rivals
Economy